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Smoking rates in the UK are at an all-time low but this masks considerable inequalities; prev-
alence amongst adults who are homeless remains four times higher than the national aver-
age. The objective of this trial was to assess the feasibility of supplying free e-cigarette
starter kits to smokers accessing homeless centres and to estimate parameters to inform a
possible future larger trial. In this feasibility cluster trial, four homeless centres in Great Brit-
ain were non-randomly allocated to either a Usual Care (UC) or E-Cigarette (EC) arm.
Smokers attending the centres were recruited by staff. UC arm participants (N = 32)
received advice to quit and signposting to the local Stop Smoking Service. EC arm partici-
pants (N = 48) received an EC starter kit and 4-weeks supply of e-liquid. Outcome measures
were recruitment and retention rates, use of ECs, smoking cessation/reduction and comple-
tion of measures required for economic evaluation. Eighty (mean age 43 years; 65% male)
of the 153 eligible participants who were invited to participate, were successfully recruited
(52%) within a five-month period, and 47 (59%) of these were retained at 24 weeks. The EC
intervention was well received with minimal negative effects and very few unintended conse-
quences (e.g. lost, theft, adding illicit substances). In both study arm, depression and anxi-
ety scores declined over the duration of the study. Substance dependence scores remained
constant. Assuming those with missing follow up data were smoking, CO validated sus-
tained abstinence at 24 weeks was 3/48 (6.25%) and 0/32 (0%) respectively for the EC and
UC arms. Almost all participants present at follow-up visits completed data collection for
healthcare service and health-related quality of life measures. Providing an e-cigarette
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starter kit to smokers experiencing homelessness was associated with reasonable recruit-
ment and retention rates and promising evidence of effectiveness and cost-effectiveness.
Introduction
Although smoking rates in the UK general population are on the decline, reaching a historic
low of 14.7% in 2018 [1], this masks significant inequalities with stubbornly high prevalence
rates among some of the most disadvantaged in society [2]. Smoking is a leading cause of
health inequality and smoking-related deaths are two to three times higher among disadvan-
taged groups [2]. Those in the most deprived groups are also more highly nicotine dependent
[3], make fewer quit attempts, and are less successful when they do make an attempt [4, 5].
Smoking prevalence amongst those experiencing homelessness has been estimated at around
57–82% based on studies predominantly deriving from the US [6]). In the UK, homeless.org
estimates prevalence at 78% [7].
Despite the high smoking prevalence amongst those experiencing homelessness, interest in
quitting and desire to stop is similar to the general population of smokers [8–10]. Nevertheless,
there have been no smoking intervention studies specifically focusing on homeless people in
the UK; the few studies that have explored the best ways to help people experiencing homeless-
ness to quit smoking derive mainly from the US. Working with this population can be chal-
lenging for research; engagement with health services, including Stop Smoking Services (SSS)
[7, 11], is generally poor and smokers experiencing homelessness may be difficult to recruit
and retain in research studies. Two studies from the US and one from Australia have explored
a range of interventions for smoking cessation in people experiencing homelessness including
motivational interviewing, cognitive behavioural therapy, quit lines, nicotine replacement
therapy (NRT) and/or other pharmacotherapies [12–14]. Point prevalence (24 hour or 7 day)
abstinence rates at 6 months were low, ranging between 4 and 13.6%. A further US study in a
small sample of homeless veterans reported a much higher 26 week past 7-day point preva-
lence abstinence rate of 45% (9/20) using contingency management (participants could earn
up to $815 for CO verified abstinence) plus NRT, bupropion and a smartphone app [15]. In
the only study reporting 6-month sustained abstinence, quit rates were 0% [13].
In a study of 24 low socioeconomic status smokers in Australia [16] feelings of guilt, shame,
stigmatisation and undesirable or unhelpful past experiences with treatment services contrib-
uted to reduced quitting success and acted as an impediment to accessing cessation support.
Similarly, a US study of perspectives on smoking cessation treatments among 25 people
experiencing homelessness [17] reported a lack of interest in established cessation approaches
such as NRT which they viewed negatively. There was a preference to engage in their own self-
defined, alternative smoking interventions, including e-cigarettes (EC).
The development and increasing sophistication of EC over the last ten years offers smokers
a viable alternative to traditional pharmacotherapies for smoking cessation. There are an esti-
mated 3.6 million current users among the general population in Great Britain [18] and
among smokers attempting to quit in England, EC continue to be the most popular method
[19]. A In a randomised controlled trial (RCT) of EC versus NRT (participants’ choice includ-
ing combinations) delivered within SSS, 12 month sustained cessation rates were almost dou-
bled in the EC arm: 18 vs 9.9% [20]. Those who opt for EC however, tend to be better educated
and higher earners [21]. Although EC are far cheaper than smoking in the longer term, they
carry an initial start-up cost which may deter those on lower incomes [22]. In a survey of 283
smokers accessing homeless services across the UK, we found that, although willingness to use
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EC was high, only 34% reported that they were willing or able to spend £20 or more on a
starter kit [10]. Reducing inequalities in health caused by smoking is a key public health prior-
ity [23, 24] and promoting smoking cessation in disadvantaged groups is central to this objec-
tive. Although EC have been used in a number of positive trials with smokers in the general
population and those with a mental health diagnosis [25] their potential for promoting smok-
ing cessation among the homeless has not been explored.
Nevertheless, the high prevalence of illicit drug and alcohol use and other physical and
mental health conditions among those experiencing homelessness [26–28] provides a further
challenge for research. Some service providers view smoking as low priority and prioritise
treatment for addictions despite evidence that those with a history of other substance use are
more likely to die from smoking related disease [29]. Concerns that attempts to quit smoking
may also exacerbate other drug use or underlying mental health conditions have also been
expressed [30, 31] although recent evidence suggests that this is not the case [32–34]. EC provi-
sion in this group could also introduce further challenges around charging, loss and breakage
as well as unintended consequences such as increased vulnerability to theft and the use of the
device for the administration of other substances [35].
Given the poor outcomes associated with the use of traditional pharmacotherapies among
people who experience homelessness who smoke, the reluctance to engage with SSS, and the
high initial start-up costs of EC, providing a free EC starter pack at a location already being
accessed by this group may help to reduce health inequalities if EC can boost quit rates. Never-
theless, due to the many uncertainties associated with EC use in this population, feasibility
work is an important precursor to a definitive trial in order to explore their acceptability and
whether smokers experiencing homelessness are willing to engage with the trial procedures.
Objectives
The overall aim of the research was to undertake a cluster controlled trial to evaluate the feasi-
bility of supplying free EC starter kits for smoking cessation to smokers accessing homeless
centres. The following specific objectives were specified.
1. Assess willingness of smokers to participate in the feasibility study to estimate recruitment
rates and inform a future trial.
2. Assess participant retention in the intervention and control arms.
3. Assess the potential efficacy of supplying free e-cigarette starter kits to determine the
required sample size for a main trial
4. Explore the feasibility of collecting data on contacts with health care services within this
population as an input to an economic evaluation in a full RCT
5. Estimate the cost of providing the intervention and usual care.
The study included an embedded qualitative process evaluation in order to examine: per-
ceived facilitators and barriers to engagement; acceptability of the EC intervention and usual
care (UC); the impact of local context; and service providers’ capacity to support the study.
These findings are reported separately.
Materials and methods
Study design and setting
This was a four-centre cluster feasibility trial with a nested qualitative process evaluation com-
ponent (reported separately). Staff administering the intervention (or UC) nor researchers
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assessing outcome could be blinded to condition due to the nature of the intervention and
study design. Participants were recruited from four homeless centres across the UK: two in
London (both residential centres), one in Northampton, and one in Edinburgh (both day cen-
tres). Although we had planned to randomise the centres to each condition, actual allocation
deviated from protocol due to centre readiness though we balanced potential confounders and
differences in environment by ensuring each cluster (EC and UC) contained one day centre
and one residential unit.
We allocated the first centre ready to work with us to the EC condition so that we could
explore recruitment, 4-week retention and any unintended consequences associated with the
intervention to determine whether to proceed with recruitment at centres 2, 3 and 4. Centre 2
(Edinburgh), as the other day centre was therefore allocated to the UC condition. Centres 3
and 4 (London) were allocated to the UC and EC arms, respectively. Centre 3 was allocated to
UC as it was geographically closer to the researcher who was still collecting follow up data
from centre 1 and we expected lower uptake in the UC condition.
Ethical approval was granted by London South Bank University (LSBU, REF: 1821) and
The Salvation Army Ethics Committee. The protocol was published on the NIHR website in
September 2018: https://fundingawards.nihr.ac.uk/award/17/44/29
Participants and recruitment
Eligible participants (see below) were invited for participation by centre staff between 7th Janu-
ary and 5th June 2019. Any smoker interested in using an EC to try to quit smoking or reduce
their smoking was eligible to take part. There was no agreement that a cessation attempt
should be made and participants did not need to be motivated to quit. Those agreeing to take
part were invited to consent and complete a baseline assessment at the homeless centre with a
member of the research team at their next visit. Although centres were allocated to condition,
participants received the same study information sheet and consent form (where they were
informed that they could be allocated to either condition) and completed baseline assessments
before being told of their condition (though due to the nature of the intervention and centre
social dynamics, participants soon became aware of centre allocation). Recruitment and 4
week follow ups ran sequentially across the three sites in England with 12 and 24 week follow
ups overlapping. Recruitment and data collection in Edinburgh ran in parallel with the second
centre in England.
Inclusion criteria. Aged 18 and over, self-reported daily smoking (confirmed by centre
staff), currently accessing homeless centre services and actively engaging with the service
(determined by centre staff). In order to represent this population of smokers as accurately as
possible, we did not exclude participants on the basis of physical/mental health diagnoses or
other use of substances.
Exclusion criteria. Currently using another smoking cessation aid, pregnant, unable to
consent (e.g. currently intoxicated or unable to speak English); not known to centre staff.
Intervention arm–EC starter kit. Homeless centre staff saw participants individually and
provided them with a starter kit comprising a tank-style refillable EC (worth £20 each) with a
choice of: a) nicotine strength e-liquid (2 options: 12 & 18mg/mL) and b) flavours (3 options:
tobacco, fruit, menthol). They also received an explanation on how to use the product and a
‘guide to e-cigarettes’ fact sheet. Participants were given time to try different flavours and nico-
tine strengths at baseline and be permitted to switch between flavours in accordance with docu-
mented vaping practices [36]. Staff also provided participants with five 10ml bottles of e-liquids
(£3 each; approx. 7mL a day) for four weeks at weekly intervals in accordance with the upper
level reported in the recent UK national survey [37] and encouraged EC charging on site.
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Control arm–Usual care. Those in the control arm were recruited in the same way as
intervention arm (EC) participants and received the same study information sheet and consent
form. After meeting the researcher to provide baseline information and being informed they
are in the UC arm, participants were referred to their keyworker/other homeless centre staff
for an individual appointment to receive brief advice to quit, and a ‘help-quit’ leaflet (adapted
from the NHS Choices website [38]) including information about the location and opening
hours of the local SSS. Paper copies of the help-quit leaflet (with SSS contact details) were avail-
able as posters/flyers at homeless centres.
To support engagement, all participants were compensated with a £15 voucher for attend-
ing each follow-up assessment as this has been shown to improve retention in other studies
with homeless smokers [39, 40].
Staff training and delivery of the intervention. The research team provided education
and training for staff at each centre one to two weeks prior to the beginning of the recruitment
period. Training lasted approximately 75 minutes for staff in the UC arm and three hours for
those in the EC arm. Content for both groups of staff included information on prevalence and
patterns of smoking among the wider population and people experiencing homelessness, the
harmful effects of smoking and benefits of quitting. The UC group received information on
the role of stop smoking services and how to make a referral to local services. The EC group
received information and practical advice on EC, specifically the evidence base of their use
among the wider population, effectiveness and safety. Also within the training session, the EC
group staff were provided with information about how to deliver correct advice about EC to
participants and given a practical hands-on demonstration relating to aspects of EC assembly,
use, charging and battery safety. Staff providing EC keyworker sessions were given additional
coaching and shadowing opportunities with the researcher.
Data collection / Measures
Baseline measures. • Demographic information and homeless status/history.
• Cigarettes smoked per day (CPD) and in the last seven days, smoking history (e.g. length of
smoking, previous number of quit attempts, support used), risky smoking practices (sharing
cigarettes, smoking discarded cigarettes, asking strangers for cigarettes) and past and current
EC use.
• Severity of tobacco dependence, measured by the Fagerström Test of Cigarette Dependence
[41] and expired carbon monoxide (CO).
• Motivation to stop smoking, measured by the Motivation to Stop Scale [42], a 7-level single-
item instrument which incorporates intention, desire and belief in quitting smoking.
• Mental health status, measured using the 9-item Patient Health Questionnaire (PHQ-9) [43]
for depression (total score ranging from 0 to 27 with a higher score indicating greater sever-
ity of depression) and the 7-item Generalised Anxiety Disorder (GAD-7) questionnaire [44]
(total score ranging from 0 to 21 with a higher score indicating greater severity of anxiety).
• Alcohol use, measured using the Alcohol Use Disorders Identification Test (AUDIT) [45], a
10-item screening instrument developed by the WHO to screen for a range of drinking
problems. Scores range from 0–40 with a score of>8 indicating harmful or hazardous drink-
ing and >13 (females) or >15 (males) indicating alcohol dependence.
• Drug use measured using The Severity of Dependence Scale (SDS) [46], a 5-item screening
measure of psychological aspects of dependence. Scores range from 0–15 (low to high
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dependence). A 23-item substance use inventory, the RaRE Use of Substances Table [47],
recorded types of drugs and substances consumed. For each item, participants indicated fre-
quency of use, 0–6 (Never to Everyday). An added question recorded which substance was
the referent for the SDS.
• General health care and service use measured using an adapted health care and social service
utilisation questionnaire.
• Health Related Quality of Life (HRQoL) measured using the EQ-5D-3L [48, 49], a generic
preference-based measure that consists of a descriptive system and a visual analogue scale
(VAS). The descriptive system can be converted to a utility value based on UK population
tariff, ranging from condition worth than death (-0.594) to perfect health (1), with 0 repre-
sents death [50]. Utility values at multiple time points can be used to derive quality-adjusted
life years (QALYs). The EQ VAS represents perceived health on the day of administration,
ranging from 0 (death) to 100 (perfect health).
All questionnaires and measures have good psychometric properties and have been used in
previous research with vulnerable populations [51–53].
Following completion of these baseline measures, participants were informed of their allo-
cated condition and then met with their keyworker or other centre staff who provided the EC
starter kit or UC (according to homeless centre allocation). A follow up appointment was then
made, and in order to minimise attrition (where possible and where consent was given) mobile
telephone numbers and email addresses were recorded in order to send text message remind-
ers ahead of scheduled appointments.
Follow up data collection. Follow up data was collected at weeks 4, 12 and 24 between 4th
February and 20th November 2019. The following information was collected: self-reported
smoking abstinence; number of cigarettes smoked; breath CO levels; engagement with the
local SSS; use of EC and other tobacco/nicotine containing products; general health care and
service use; HRQoL (EQ-5D-3L); mental health status (GAD-7, PHQ-9); other drug use/
dependence (AUDIT, SDS); direct and indirect staff contact time. For those in the EC arm,
we additionally measured 12 positive (e.g. throat hit, satisfaction, pleasant, craving reduction)
and 21 negative effects (e.g. mouth/throat irritation, nausea, headache, heartburn) of EC use
using a Visual Analogue Scales (VAS) and summed to create a percentage score (higher
score = higher positive or negative effect) as used in our previous studies [54, 55]. To further
monitor risk and adverse effects (e.g. EC theft, exchanges, use for other substances), we utilised
a purposefully developed unintended consequences checklist. A £15 love to shop voucher was
provided for each follow up.
Feasibility outcome measures
1. To assess willingness to take part in the trial, we recorded the number of people who were
asked, and the number who consented, to take part.
2. Retention and engagement was measured by recording a) the proportion of participants: i)
still using EC in the intervention arm and ii) who had visited the SSS in the UC arm; and b)
the proportion of participants who completed assessment measures in each arm at each
time point.
3. To assess the potential efficacy of supplying free EC starter kits, at each follow up point, we
recorded: a) CO-validated (<8ppm) sustained abstinence (from 2-weeks post-quit date
allowing up to 5 slips; the gold ‘Russell Standard’ in smoking cessation research) [56]; b)
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CO-validated 7-day point prevalence abstinence (i.e. no smoking at all in the last 7 days),
the most commonly reported outcome measure in studies of smoking cessation in people
experiencing homelessness [6]; and c) the proportion achieving 50% smoking reduction, a
common outcome measure used in EC cessation studies [57] (calculated by subtracting
CPD at follow up from baseline).
4. To explore the feasibility of collecting data on contacts with health care services we
recorded participant utilisation of primary and secondary health care services using a self-
report questionnaire
5. Staff contact time, non-contact time and other resources used in the delivery including staff
costs, e-cigarettes and other costs incurred was collected to provide an indicative cost of the
intervention.
Sample size
As this is a feasibility study, a formal power calculation based on detecting evidence for efficacy
was not conducted; indeed, an aim of the feasibility study was to calculate the required sample
size (and an intra class correlation coefficient (ICC) for a possible future definitive cluster
RCT. Our original recruitment goal was 120 within a 5 month period; that is, approximately
30 per centre, with sampling from centres taking place consecutively. This was based on our
preliminary scoping work suggesting that each homeless centre has contact with between 25
and 120 homeless clients every day of whom 70–90% are likely to be smokers. Other studies in
homeless populations have reported follow-up rates ranging between 24% and 88% (depend-
ing on the location of visits, provision of incentives & use of prompts, see Richards et al. 2015
[40]). Therefore, estimating that 50% of those who agree would drop out in the period between
consenting to participate and the final follow up at 24 weeks, the sample size at the final follow
up was estimated to be a minimum of 60. This was a pragmatically chosen sample size, based
on the information available to us at the time, to allow us to identify evidence of feasibility,
recruitment rates and any problems with the intervention or research methods.
Data analysis
Our feasibility data were analysed according to our protocol https://fundingawards.nihr.ac.uk/
award/17/44/29. To address objectives 1 and 2 willingness to participate and retention, we
present frequency information regarding the number of eligible smokers who: i) were invited
to take part; ii) consented/completed the baseline assessment; iii) attended and completed
each follow up; and iv) were still engaging with the treatment/UC at each follow up.
Baseline demographic information is summarised using frequencies and descriptive statis-
tics and the arms (EC v UC) are compared using t-tests, Mann- Whitney U tests or Fisher’s
Exact test as appropriate. EC effects are summarised descriptively.
To assess the potential efficacy of supplying free EC starter kits and to inform the sample size
for a future larger trial (objective 3), we summarise the proportion of participants reporting sus-
tained smoking abstinence (CO verified), 7-day point prevalence abstinence, and a 50% reduc-
tion in smoking in each arm at each follow up time point. The main sample size calculation is
based on 24 week sustained abstinence using intention to treat analysis; that is, all those rando-
mised are included in the analysis as belonging to the group to which they were randomised
and those with missing outcome data were treated as smokers. The planned analysis was to use
generalised linear mixed effects models to estimate the clustering of observations within centres.
From these models we would also estimate the effect size of the intervention after adjustment
for covariates. The ICC was to be estimated from the random intercept model.
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To explore feasibility of collecting data using self-report questionnaire, we administered
EQ-5D-3L and healthcare and social service questionnaire to participants and examined the
completeness of the responses and the frequency of each service use. We presented QALYs
derived from EQ-5D-3L using the area under the curve approach [58] and costs of general
healthcare services at each time point, by arm, to show a preliminary profile of costs and
HRQoL. To provide an indicative cost of intervention, we estimated the costs of pre-interven-
tion training and intervention delivery, based on relevant staff activities.
For the primary outcome, participants lost to follow up were assumed to be smoking and
included at follow up. For assessment of the relationship between other variables and out-




One hundred and seventy seven participants were invited to participate (106 in the EC arm
and 71 in the UC arm). Of these, 24 were not eligible (16 in the EC arm; 8 in the UC arm). Rea-
sons for exclusion were: persons presenting were non-smokers, pregnant, unknown to centre
staff, assessed to be unable to provide informed consent due to levels of intoxication, or
assessed by staff to have high mental health risk or self-care burden. Of the 153 eligible partici-
pants, 80 consented, completed baseline assessments and were randomised: 48 (53%) in the
EC arm and 32 (51%) in the UC arm. Fig 1 shows the CONSORT flow diagram and recruit-
ment and retention figures by centre can be found in S1 Table.
Demographic and smoking related characteristics
As presented in Table 1, the mean age for the total sample was 42.66 years and 65% were male.
Participants were primarily white (76.3%), heterosexual (85%) and 37.6% were educated to A-
level (or equivalent) or higher. Employment status varied with only 2.5% currently in paid
employment and 97.5% were in receipt of public funds (welfare benefits). Just over half of the
sample (60%) were currently housed in supported accommodation or in a hostel. Seventy-four
percent of the sample reported a long-standing illness, 38.8% had been admitted to hospital
due to mental illness and 50% had previously spent time in prison. The mean number of ciga-
rettes smoked per day was 20 and most participants reported that they had started smoking
during their teenage years (M = 15 years). Baseline expired CO was 20.29 ppm and the mean
FTCD score was 5.51. Fifty five percent reported that they shared cigarettes, 43% reported that
they had smoked discarded cigarettes and 40% had asked strangers for cigarettes at least occa-
sionally. Motivation to stop smoking (MTSS) varied considerably although only 6.3% reported
that they did not want to stop smoking. Mean scores on the GAD-7 (11.22) and PHQ-9
(12.93) were in the moderate/moderately severe range for anxiety and depression and the
mean AUDIT score (9.22) suggests that on average, participants were drinking at harmful/haz-
ardous levels. The EC and UC arms differed on several variables: the proportion of participants
who had previously spent time in prison or who had a long-standing illness, disability or infir-
mity was significantly higher in the UC than EC arm. UC arm participants also scored higher
on anxiety and substance dependence and were less motivated to quit smoking (see Table 1).
Follow up and retention
Retention rates (percentage of those allocated) were 75%, 65% and 59% respectively at 4, 12
and 24 weeks and retention was higher in the EC arm. Loss to follow up occurred mainly
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Fig 1. CONSORT flow diagram.
https://doi.org/10.1371/journal.pone.0240968.g001
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Table 1. Participant baseline characteristics.
Total N = 80 EC arm UC arm P value
Age (in years): mean (SD) 42.66 (10.79) 42.75 (10.90) 42.53 (10.78) .93
Gender: N (%) .34
Female 28 (35) 19 (40) 9 (28.13)
Male 52 (65) 29 (60) 23 (71.88)
Employment status N (%) .11
Full time school or college 0 (0) 0 (0) 0 (0)
Paid employment/self-employed 2 (2.5) 2 (4.16) 0 (0)
Government training scheme 2 (2.5) 1 (2.08) 1 (3.13)
Unpaid or voluntary work 9 (11.3) 9 (18.75) 0 (0)
Waiting to work, already obtained 1 (1.3) 1 (2.08) 0 (0)
Looking for work/training scheme 12 (15.0) 7 (14.58) 5 (15.63)
Prevented by temporary sickness/injury 5 (6.3) 2 (4.16) 3 (9.38)
Permanently unable to work 38 (47.5) 21 (43.75) 17 (53.13)
Unemployed and not looking for work 5 (6.3) 3 (6.25) 2 (6.25)
Other 6 (7.5) 2 (4.16) 4 (12.5)
Current sleeping situation (last 7 days): N (%)�
Sleeping rough on streets/park 7 (8.8) 3 (6.25) 4 (12.5) .42
Hostel or supported accommodation 48 (60) 31 (64.58) 17 (53.13) .36
Sleeping on somebody’s floor/sofa 3 (3.8) 1 (2.08) 2 (6.25) .56
Emergency accommodation (refuge, shelter) 9 (11.3) 8 (16.66) 1 (3.13) .08
B&B or temporary accommodation 2 (2.5) 1 (2.08) 1 (3.13) 1.00
Housed–own tenancy 18 (22.5) 8 (16.66) 10 (31.25) .17
Other 2 (2.5) 2 (4.16) 0 (0) .51
Backgrounds: N (%)�
Spent time in prison 40 (50) 19 (40) 21 (65.63) .04
Spent time in secure/young offender unit 18 (22.5) 9 (18.75) 9 (28.13) .41
Spent time in local authority care 17 (21.3) 7 (14.58) 10 (31.25) .10
Spent time in the armed forces 7 (8.8) 3 (6.25) 4 (12.5) .43
Admitted to hospital due to mental illness 31 (38.8) 18 (37.5) 13 (40.63) 1.00
Been a victim of domestic violence 31 (38.8) 18 (37.5) 13 (40.63) 1.00
Highest level of education: N (%) .40
School (stopped prior to GCSE/standard grade 24 (30) 17 (35.42) 7 (21.88)
School (GCSE/Standard grade) 26 (32.5) 13 (27.08) 13 (40.63)
College (A-level/FE/Highers) 25 (31.3) 15 (31.25) 10 (31.25)
University (degree level) 4 (5) 3 (6.25) 1 (3.13)
University (post-graduate, higher level) 1 (1.3) 0 (0) 1 (3.13)
Ethnicity: N (%) .64
White 61 (76.3) 35 (72.92) 26 (81.25)
Asian/Asian British 2 (2.6) 6 (12.50) 2 (6.25)
Black/Black British 9 (11.4) 2 (4.17)) 0 (0)
Mixed race/multiple ethnic groups 8 (10.2) 5 (10.42) 4 (12.5)
Sexual Orientation: N (%) .81
Heterosexual or straight 68 (85) 40 (83.33) 28 (87.5)
Gay or lesbian 1 (1.3) 1 (2.08) 0 (0)
Bi-sexual 3 (3.8) 2 (4.16) 1 (3.13)
Prefer to self-define 3 (3.8) 2 (4.16) 1 (3.13)
Prefer not to say 3 (3.8) 3 (6.25) 0 (0)
Missing 2 (2.5) 0 (0) 2 (6.25)
(Continued)
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Table 1. (Continued)
Total N = 80 EC arm UC arm P value
Immigration Status: N (%) .68
UK National 74 (92.5) 45 (93.75) 29 (90.63)
European Economic Area (EEA) national 6 (7.5) 3 (6.25) 3 (9.38)
Receiving public Funds (Benefits): N (%) .16
Yes 78 (97.5) 48 (100) 30 (93.75)
No 2 (2.5) 0 (0) 2 (6.25)
Long-standing illness, disability, infirmity: N (%) .02
Yes 59 (73.8) 30 (62.5) 29 (90.63)
No 16 (20) 13 (27.08) 3 (9.38)
Prefer to self-define 4 (5) 4 (8.33) 0 (0)
Prefer not to say 1 (1.3) 1 (2.08) 0 (0)
Number of cigarettes/day: mean (SD) 20.07 (15.33) 20.5 (16.78) 19.41 (13.07) .86
Expired CO: mean (SD) 20.29 (10.04) 19.60 (9.58) 21.31 (10.77) .46
FTCD: mean (SD) 5.51 (2.47) 5.24 (2.53) 6.13 (2.35) .12
Age started smoking: mean (SD) 15.17 (5.47) 16.02 (6.30) 13.92 (3.72) .09
Sharing cigarettes: N (%) .10
Not at all 35 (43.8) 25 (52.08) 9 (28.13)
Occasionally 18 (22.5) 10 (20.83) 7 (21.88)
Regularly 7 (8.8) 3 (6.25) 5 (15.63)
Daily 19 (23.8) 9 (18.75) 11 (34.38)
Smoke discarded cigarettes: N (%) .43
Not at all 45 (56.3) 30 (62.5) 15 (46.88)
Occasionally 22 (27.5) 12 (25) 10 (31.25)
Regularly 7 (8.8) 3 (6.25) 4 (12.5)
Daily 5 (6.3) 2 (4.16) 3 (9.38)
Ask strangers for cigarettes: N (%) .35
Not at all 47 (58.8) 31 (64.58) 16 (50)
Occasionally 21 (26.3) 12 (25) 9 (28.13)
Regularly 5 (6.3) 2 (4.16) 3 (9.38)
Daily 6 (7.5) 2 (4.16) 4 (12.5)
MTSS: N (%) .04
I don’t want to stop smoking 5 (6.3) 1 (2.08) 4 (12.5)
I think I should stop but don’t really want to 8 (10) 4 (8.33) 4 (12.5)
I want to stop but haven’t thought about when 14 (17.5) 6 (12.5) 4 (12.5)
I really want to stop but I don’t know when I will 11 (13.8) 3 (6.25) 8 (25)
I want to stop smoking and hope to soon 18 (22.5) 16 (33.33) 5 (15.63)
I really want to stop & intend to within 3 months 7 (8.8) 5 (10.42) 3 (9.38)
I really want to stop and intend to within 1 month 14 (17.5) 11 (22.92) 3 (9.38)
Missing 3 (3.8) 2 (4.16) 1 (3.13)
Importance of quitting at this attempt: N (%) .25
Desperately important 13 (16.3) 10 (20.83) 3 (9.38)
Very important 38 (47.5) 25 (52.08) 15 (46.88)
Quite important 19 (23.8) 7 (14.58) 10 (31.25)
Not at all important 8 (10) 5 (10.42) 3 (9.38)
(Continued)
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between 12 and 24 weeks in the UC arm primarily because participants were no longer attend-
ing the homeless service. The flow of participants through the study is shown in the CON-
SORT diagram in Fig 1 and retention rates at each centre are shown in S1 Table.
Of those participants in the EC arm who attended follow ups and answered the question:
33/39 (85%), 28/34 (82%) and 22/35 (63%) reported that they still had the e-cigarette that
we provided at 4, 12 and 24 weeks respectively. The number of participants who reported
that they were still using an e-cigarette (either the one we provided or a different one)
was 37/39 (95%), 30/33 (91%) and 27/34 (79%) at 4, 12 and 24 week respectively. In the
UC arm, 4/16 (25%) participants who attended the 4 week follow up reported that they had
followed the recommendation to attend the SSS. No additional participants attended
between weeks 4 and 24 (although 2 of the 4 initial attendees reporting attending more than
once).
E-cigarette use, effects and unintended consequences in the EC arm
At 4 weeks, of those attending follow up appointments (N = 39) three (8%) participants
reported that they had lost their e-cigarette, three (8%) reported that it had been stolen, one
(3%) had swapped it and 14 (36%) reported that it had broken (see Table 2). The most fre-
quently reported reason for breakage was that the e-cigarette had been dropped and the glass
tank broke. Three of 39 (8%) participants reported that they had purchased their own EC at
4-weeks, 4/34 (12%) at 12 weeks and 11/35 (31%) at 24 weeks. No participants reported adding
any other substance to their e-cigarette at any follow up time point although two reported that
they had previously added THC or CBD oil to a different device. Self-reported negative effects
were rare with a mean percentage score of 13.73 (12.95) at 4 weeks (Table 3; data from 12 and
24 weeks are not presented as this fell beyond the period of our e-liquid provision but are avail-
able upon request). The highest scoring negative effect was ‘nervous’ (M = 19.97 SD = 29.01)
followed by ‘headache’ (M = 18.54, SD = 28.49). In terms of positive effects (Table 3), the mean
total percentage score was 49.51 (18.39). The highest scoring positive effects were ‘pleasant’
(M = 73.79, SD = 22.60) and ‘tastes good’ (71.92, SD = 25.21) and the lowest scoring positive
effect was ‘tastes like my usual brand’ (M = 19.97, SD 29.85).
Table 1. (Continued)
Total N = 80 EC arm UC arm P value
Determination to quit at this attempt: N (%) .52
Extremely determined 19 (23.8) 13 (27.08) 6 (18.75)
Very determined 26 (32.5) 16 (33.33) 10 (31.25)
Quite determined 24 (30.5) 14 (29.16) 10 (31.25)
Not at all determined 8 (10.0) 3 (6.25) 5 (15.63)
Missing 3 (3.8)
Self-rated chance of quitting (1 = very low– 6 = extremely high): median (IQR) 4 (2) 4(1) 4 (1) .23
GAD-7: median (IQR) 11 (13 10 (11) 16 (13) .03
PHQ-9: median (IQR) 14 (14.5) 13.5 (13) 15.5 (16) .45
AUDIT: median (IQR) 5.5 (13) 5 (17) 6.5 (11) 1.0
SDS: median (IQR) 3 (5.5) 2 (7) 8 (8) < .01
�Participants could select more than one option. MTSS = Motivation to Stop Smoking Scale: GAD-7 = Generalised Anxiety Disorder Questionnaire: PHQ-9 = Patient
Health Questionnaire; AUDIT = Alcohol Use Disorders Identification Test; SDS = Severity of Dependence Scale
T-tests/Mann Whitney U used for continuous variables. Fishers Exact Test used for categorical variables.
https://doi.org/10.1371/journal.pone.0240968.t001
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Mental health and substance use
Mean (SD) scores for the mental health and substance use measures for those participants who
were retained in the study through to the 24 week follow up are presented in Table 4. Both
GAD-7 anxiety and PHQ-9 depression scores showed a steadily decline from baseline to the
24 week follow up. A similar decline in AUDIT scores was also evident although SDS remained
stable.
Smoking outcome data
Table 5 presents the smoking related outcome measures. Of those who could be followed up,
the CO validated sustained abstinence rate at 24 weeks was 3/35 (11%) for the EC arm and 0/
12 (0%) for the UC arm. Assuming that all those with missing follow up data were smoking
(intention to treat), the 24 week sustained abstinence rate was 6.25% (3/48) in the EC arm vs.
0/32 (0%) in the UC arm. Seven day point prevalence rates at 24 weeks were the same as sus-
tained abstinence rates. The percentage of participants who reported >50% reduction in CPD
from baseline to 24 week follow up was 43% in the EC arm and 25% in the UC arm. The
Table 2. E-cigarette events at 4, 12 and 24 weeks.
4-weeks: YES
N %
E-cig lost: N (%) 3/39 8
E-cig stolen: N (%) 3/39 8
Sold: N (%) 0/39 0
Exchanged/swapped: N (%) 1/39 3
Given away N (%) 0/39 0
Broken: N (%) 14/39 36
Added substance?: N (%) 0/39 0
12 weeks�
E-cig lost (%) 2 /32 6
E-cig stolen 1/32 3
Sold 0/32 0
Exchanged/swapped 0/32 0
Given away 1/32 3
Broken 11/31 35
Added substance? 0/34 0
24 weeks�
E-cig lost (%) 2/33 6
E-cig stolen 2/33 6
Sold 0/33 0
Exchanged/swapped 0/33 0
Given away 2/33 6
Broken 11/33 33
Added substance? 0/34 0
N = number reporting / number who attended that session
� Although participants were asked “since the last meeting”, some of the 12 and 24 week responses relate to
breakages, loss etc. from the previous time point so these cannot be considered additional breakages, losses etc. Some
participants reported exchanging or giving away devices because they broke. Some participants reported replacing
devices which subsequently broke or were lost, stolen etc.
https://doi.org/10.1371/journal.pone.0240968.t002
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percentage of those with >50% reduction in expired CO was a little lower and similar in the
two groups (EC = 20%; UC = 25%). The number of people reporting that they shared cigarettes
remained relatively stable across the 24 weeks although reports of smoking discarded cigarettes
and asking strangers for cigarettes decreased (data in S2 Table).
Intraclass correlation coefficient estimation
The planned analysis included the fitting of a binary logistic mixed effects models for the pur-
pose of estimating the intraclass correlation coefficient based on the random intercept. It was
not possible to achieve convergence for the mixed effects model within the attained sample so
the intraclass correlation coefficient is calculated by the Fleiss-Cuzick method [59] and the
point estimate is 0.0157. The intra class correlation coefficient is the ‘proportion of the total
variance in the outcome attributable to variance between clusters’ [59]. Although the estimated
ICC is relatively small [60] neglecting to factor this in to the sample size calculation for a full
scale cluster randomised controlled trial would result in reduced statistical power.
E-cigarette use in the UC arm
Four of the 21 UC participants (19%) tested at the 4-week follow up reported that they had
purchased an EC. At 12 and 24 weeks respectively a further 1/18 (5.6%) and 2/12 (16.7%)
reported that they had made an EC purchase. Any use of an EC during the study period was
reported by 9/14 (64%) participants at 4 weeks, 5/18 (28%) at 12 weeks and 4/12 (33%) partici-
pants at 24 weeks.
Table 3. Self-reported negative and positive effects at week 4 in the E-cigarette arm.
Negative Effect Mean (SD) Positive Effect Mean (SD)
Nervous 19.97 (29.01) Pleasant 73.79 (22.60)
Headache 18.54 (28.49) Tastes good 71.92 (25.21)
Sweaty 18.46 (22.73) Satisfying 70.56 (26.84)
Weak 18.13 (21.56) Craving 69.49 (30.66)
Nausea 17.38 (25.45) Calmer 53.38 (33.50)
Heart pounding 17.36 (28.30) Nicotine hit 52.05 (36.95)
Light headed 14.67 (20.55) Throat hit 47.77 (34.48)
Confused 14.21 (21.94) Concentration 46.08 (37.37)
Dizzy 14.10 (21.66) Awake 37.95 (36.84)
Hiccups 14.00 (23.53) Hunger 27.95 (31.83)
Stomach ache 13.59 (20.89) Feels like usual brand/model 23.15 (32.18)
Salivation 13.46 (21.40) Tastes like usual brand/model 19.97 (29.85)
Mouth irritation 13.38 (22.25)
Flatulence/bloating 13.36 (23.65)
Throat irritation 12.49 (17.54)
Cold hands/feet 11.31 (22.04)
Palpitations 10.44 (15.91)




TOTAL 13.73 (12.95) TOTAL 49.51 (18.39)
(N = 39) Scores are expressed as a percentage converted from Visual Analogue Scales.
https://doi.org/10.1371/journal.pone.0240968.t003
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Data collection for an economic evaluation
Missing information on both EQ-5D-3L and general healthcare services questionnaire was
largely due to participants’ absence at the time of interviews. For those who attended the inter-
view, there were few cases of items missing.
Amongst observed cases, the proportion of participants scoring no problem on EQ-5D-3L
was consistently higher in the EC arm than the UC arm across all domains and all time points.
Consequently, mean utility scores in the EC arm were higher amongst those competing the
measure (Table 6). For those completing EQ-5D-3L at all time points, mean QALY was 0.195
(SD 0.097) in the UC arm (n = 11) and 0.315 (SD 0.120) in the EC arm (n = 26), over 24
weeks.
Compared with the EC arm, the UC arm showed an indication of relying more on SSS and
NRT. When the EC arm were no longer offered sessions from keyworkers, they turned to GPs,
practice nurses or pharmacists for help (see S3 Table). No use of NHS SSS helplines was
reported throughout the study period.
Community-based services (maternity service, sex health clinic, early intervention team,
detox/rehab unit) were rarely used in either arm. Other services such as drug and alcohol ser-
vice, adult mental health team and housing team were used more often. While GP and practice
Table 4. Mental health and substance use at baseline and each follow up time point for the e-cigarette (EC) and
usual care (UC) arms.
Total EC Arm UC Arm
GAD-7
N 37 27 10
Baseline: Mean (SD) 10.08 (6.91) 8.48 (6.81) 14.40 (5.36)
4 weeks: Mean (SD) 9.11 (6.81) 7.15 6.38) 14.40 (5.02)
12 weeks: Mean (SD) 8.27 (7.12) 6.44 (6.54) 13.20 (6.49)
24 weeks: Mean (SD) 7.54 (6.64) 5.63 (6.34) 12.70 (4.42)
PHQ-9
N 36 25 11
Baseline: Mean (SD) 11.53 (8.26) 10.76 (8.34) 13.27 (8.17)
4 weeks: Mean (SD) 10.53 (7.62) 9.08 (7.76) 13.82 (6.46)
12 weeks: Mean (SD) 9.92 (8.03) 8.36 (7.53) 13.45 (8.37)
24 weeks: Mean (SD) 8.25 (7.38) 7.12 (7.22) 10.82 (7.23)
AUDIT
N 35 24 11
Baseline: Mean (SD) 10.60 (11.07) 11.83 (12.15) 7.91 (8.08)
4 weeks: Mean (SD) 7.86 (9.34) 9.08 (9.76) 5.18 (8.48)
12 weeks: Mean (SD) 8.57 (9.72) 10.29 (10.37) 4.82 (7.15)
24 weeks: Mean (SD) 8.00 (8.47) 8.92 (8.83) 6.00 (7.64)
SDS
N 37 27 10
Baseline: Mean (SD) 3.81 (5.05) 3.15 (4.33) 5.50 (6.52)
4 weeks: Mean (SD) 3.19 (4.48) 2.81 (4.51) 4.20 (4.49)
12 weeks: Mean (SD) 3.78 (4.15) 3.35 (4.05) 4.90 (4.41)
24 weeks: Mean (SD) 3.78 (4.33) 3.23 (4.46) 5.20 (3.82)
GAD-7 = Generalised Anxiety Disorder Questionnaire: PHQ-9 = Patient Health Questionnaire; AUDIT = Alcohol
Use Disorders Identification Test; SDS = Severity of Dependence Scale
https://doi.org/10.1371/journal.pone.0240968.t004
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nurse services were used more frequently, home visits were rare. The majority of participants
in either arm received at least one prescription at each time point. Accident and Emergency (A
& E) and hospital visits were reported in both arms at all time points.
The mean costs among observed cases were consistently higher in the UC arm than in the
EC arm (Table 6). The difference up to 12 weeks was mostly due to the longer hospital stay in
the UC arm. At 24 weeks, although the mean cost of hospital stay and drug/alcohol service in
the EC arm was much higher, the mean cost of A & E, early intervention team and adult men-
tal health team offset the reducing costs in other services in the UC arm.
Table 5. Frequencies and percentages for smoking related outcome variables at baseline and each follow up time
point for the e-cigarette (EC) and usual care (UC) arms.
EC Arm UC Arm
Sustained abstinence
4 weeks: N (%) 8/39 (21%) 0/21 (0%)
12 weeks: N (%) 2/34 (6%) 0/18 (0%)
24 weeks: N (%) 3/35 (11%) 0/12 (0%)
7 day point prevalence
4 weeks 7/39 (18%) 0/21 (0%)
12 weeks 5/34 (15%) 0/18 (0%)
24 weeks 3/35 (9%) 0/12 (0%)
50% reduction in CPD
4 weeks 21/39 (54%) 4/21 (19%)
12 weeks 20/34 (59%) 4/18 (22%)
24 weeks 15/35 (43%) 3/12 (25%)
50% reduction in expired CO
4 weeks 10/39 (26%) 2/21 (10%)
12 weeks 7/34 (21%) 1/18 (6%)
24 weeks 7/35 (20%) 3/12 (25%)
N = number meeting criteria / number attending the session
https://doi.org/10.1371/journal.pone.0240968.t005
Table 6. Mean EQ-5D-3L utility value, EQ VAS and costs of general healthcare and social services at each time point, by arm.
UC (n = 32) EC (n = 48)
n Mean (SD) n Mean (SD)
EQ-5D-3L
Utility EQ VAS Utility EQ VAS
Baseline 31 0.394 (0.362) 57.0 (21.7) 46 0.548 (0.341) 52.7 (20.7)
4 weeks 21 0.330 (0.308) 48.6 (24.7) 39 0.602 (0.346) 61.4 (21.5)
12 weeks 18 0.350 (0.351) 59.3 (22.7) 33 0.683 (0.309) 65.6 (21.3)
24 weeks 12 0.619 (0.238) 61.0 (22.5) 34 0.653 (0.363) 61.8 (21.6)
Costs of general healthcare and social services
Costs Costs
Baseline 31 £1,480 (£3,188) 47 £518 (£754)
4 weeks 21 £1,559 (£4,489) 39 £539 (£987)
12 weeks 18 £957 (£1,849) 34 £682 (£885)
24 weeks 12 £1,207 (£1,494) 35 £1,172 (£1,952)
https://doi.org/10.1371/journal.pone.0240968.t006
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Costs of the intervention
The costs of staff time in delivering EC training was £1,041 in total and UC training was £247.
The costs of staff time in attending the training were £803 in the EC arm and £185 in the UC
arm. The costs of e-cigarette and e-liquid used were £138. The pamphlets for EC training were
printed at £8 in total and for UC training at £2.40 in total. In EC training, six e-cigarette
devices were given to the centre staff who smoke, costing £120. The costs of inter-city travel-
ling, travelling time, accommodation and meals were estimated at £294 in the EC arm and
£1,143 in the UC arm. In total, the training costs for the UC arm were £1,577 and for the EC
arm £2,403. Allocating evenly to participants in each arm, it was £49.27 per participant in the
UC arm and £50.07 per participant in the EC arm. Due to the staff capability, the data on deliv-
ery sessions were not collected in the UC arm. We therefore did not know the attendance of
weekly sessions (visit 0–3).
For the EC arm, 47 out of 48 participants attended visit 0with staff and received an EC
starter kit and five bottles of e-liquid (235 bottles in total), 46 of which also received pamphlets
of e-cigarette device instruction with one missing. At visits 1, 2 and 3, an additional 147, 114
and 110 bottles of e-liquid were supplied totalling 606 across the four weeks (see S4 Table for a
breakdown of flavours and nicotine strengths supplied at each time point). Except for missing
or absent at visit, the mean duration of visit 0 was 25 minutes (SD 16 minutes, range 7–80,
n = 46), of visit 1 was 8 minutes (SD 4 minutes, range 1–20, n = 29), of visit 2 was 6 minutes
(SD 3 minutes, range 1–15, n = 21), and of visit 3 was 5 minutes (SD 2 minutes, range 2–10,
n = 20). Visits 1–3 were fairly short as they mainly involved supplying further bottles of e-
liquid.
The mean costs of EC starter kit and e-liquid were £57.46 (SD £19.91) among the 48 partici-
pants in the EC arm. The mean cost of pamphlet was £0.39 (SD £0.06) among 47 participants
in the arm. The mean costs of sessions were £7.51 (SD £4.60) among 43 participants. The costs
of intervention delivery were therefore estimated for 43 participants whose data were complete
in this part and it was £64.35 (SD £22.89) per participant.
In total, the mean costs of EC intervention, including training and delivery, were estimated
to be £114.42 (SD £22.89) among 43 participants in the EC arm, with five participants with
incomplete information.
Main RCT sample size calculation
Based on the proportions with sustained CO validated abstinence in each arm (6.25% in inter-
vention 0% in usual care) and assuming 0.05 alpha, 90% power and intraclass correlation coef-
ficient of 0.01, 12 participants per cluster (the feasibility study average) a full trial would
require 16 sites per arm, and the study would need to enrol 192 participants per arm, 384 par-
ticipants in total. ICC is estimated at 0.01 as it is anticipated the inclusion of individual level
predictors will further reduce the ICC from the estimate calculated without adjustment.
This sample size estimate assumes equal cluster sizes. These estimates are not adjusted for
attrition as it is anticipated that the primary analysis will be by intention to treat and partici-
pants lost to follow up assumed to have relapsed entailing no loss of power.
Discussion
In the first attempt worldwide to explore supplying free EC starter kits to smokers accessing
homeless centres, this feasibility trial captured data on participant recruitment, retention,
engagement and preliminary efficacy and cost-effectiveness.
In terms of willingness to participate, just over half of eligible participants invited, con-
sented to take part and completed baseline assessments. The study also provided useful
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information and insights into the types of homeless centres to include in a future main cRCT;
the number of eligible participants varied considerably across centres with the two residential
centres offering fewer eligible participants (due to both the smaller size of the centres and a
lower proportion of smokers). The two day-care centres were the most successful in terms of
recruitment, together accounting for over two thirds of the total sample. Willingness to engage
in the study at the centre in Northampton was particularly high and participants on the wait-
ing list could not be recruited to the study due to criteria of recruiting across different sites.
That we were able to recruit 80 participants across four centres in a five-month period despite
the limited pool of participants at the residential centres is encouraging for a future main trial.
Retention is likely to be an issue when engaging with people accessing homeless centres as
their circumstances can be unpredictable and quickly liable to change. The overall 24 week
total retention rate was 59% which compares favourably with other smoking cessation studies
in this population [6]. Retention was also much higher in the EC compared with the UC arm.
This could reflect the nature of the intervention although the arms also differed on several
important baseline characteristics with the UC group evidencing higher levels of long-standing
illness, time spent in prison, substance dependence and anxiety which may militate against fol-
low up attendance. However, there were also differences in retention rates between the 2 UC
centres and the difference in retention between arms was driven largely by the low 24 week fol-
low up rate at the Edinburgh centre where, despite our best efforts (text message reminders,
incentives), many participants had moved on and were no longer accessing the homeless cen-
tre services.
Given the clinical and environmental factors specific to this population, it was recognised
that EC may become lost, damaged, sold, or stolen. Encouragingly, reports of selling, exchang-
ing or theft were infrequent. Although some reported breakages, most commonly through
dropping the device which lead to broken tanks and electrical faults, the majority of partici-
pants still had and were still using either the EC that we provided or a different one. Critically,
use continued after the end of the 4-week e-liquid supply period suggesting that our partici-
pants were willing to source their own e-liquid after the initial start-up costs are covered.
One concern that was not borne out, was that since 40% of smokers experiencing homeless-
ness are dependent on other substances [61], there may be a temptation to use the EC for vap-
ing illicit drugs. This is a trend that has been described in recent years by drug users in online
forums, blogs and videos, though there is very little research on the topic. A recent study (a
modest online survey using a convenience sample in the UK), reported that 39.5% of those
using an EC had used it for recreational drug administration in their life time [35]. Most com-
monly reported was cannabis vaping; 18% of EC users reported lifetime use and 10.6% had
used in the last 30 days. Although cannabis use was common in our sample, no participants
reported adding cannabis (synthetic or otherwise) or any other illicit drug to the EC provided
by the study during the 24 week study period.
Encouragingly, EC were well tolerated with high scores for self-reported positive effects e.g.
‘pleasant’ and ‘tastes good’. Self-reported negative effects were rare; the highest scoring items
on our VAS of negative effects were nausea and headache, both with an average severity score
of less than 20%. Interestingly, these symptoms differ to those reported in other studies; using
the same VAS for negative effects, we have previously found that throat irritation, mouth irri-
tation and light-headedness are generally the most commonly experienced negative effects in
smokers and EC users (although ratings are still low) whilst nervousness and headache are less
typical [54, 62, 63].
As expected, our sample scored highly on measures of anxiety, depression, alcohol misuse
and substance disorder at baseline. Encouragingly, illicit substance use (SDS) remained stable
over time and GAD-7, PHQ-9 and AUDIT scores declined from baseline to follow up
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suggesting that mental health and alcohol misuse do not get worse during a quit attempt and
showed a slight improvement. This is consistent with previous research which has demon-
strated that stopping smoking is associated with an improvement in mental health symptoms
[34]. This is an important finding; in our recent systematic review, we report that professionals
working within the homeless sector are often concerned about worsening mental illness or
current substance use [6] and this has been a key barrier to both starting discussions around
smoking and also implementing smoking cessation programmes. Health professionals should
find the growing evidence that smoking cessation does not counter progress with other mental
health symptoms in adults with complex needs reassuring. The potential benefits of cessation
on mental wellbeing would be explored in a future trial.
E-cigarettes were well-received in the EC arm with the majority reporting that they still
had, and were still using, the e-cigarette at the 24 week follow up. By 24 weeks, 31% had also
made their own EC purchase which may explain why the number of people reporting use
exceeded those who reported that they still had the EC we supplied. As has been reported in
other feasibility studies of EC [64], and despite our cluster design, EC use was also commonly
reported in the UC arm. We did not explore the extent of this use (e.g. regular use of their own
device or just a few puffs of someone else’s) and we did not explicitly ask UC participants not
to use an EC. However, none of the UC participants received the EC intervention as delivered
(i.e. a free EC starter kit offered at homeless centres). Although contamination across arms can
be a problem for many RCTs, supported use of an EC is increasingly being incorporated into
the ‘usual care’ offered by SSS and should not, therefore invalidate our findings. The pragmatic
question that will be explored in a main trial will be whether the provision of a free EC starter
kit, offered at a location already being accessed by people experiencing homelessness, can
increase smoking cessation rates over usual care.
Our feasibility study results suggest that the EC intervention may have the potential to
enhance smoking cessation rates in this population with a 6% sustained CO-verified absti-
nence rate at 24 weeks (intention to treat) compared to 0% in the UC group. Although cessa-
tion rates were low, if similar effects are found in a fully powered RCT, this could substantially
contribute to reducing smoking-related inequalities given the high rates of smoking in this
population. Notably, no other smoking cessation studies with people experiencing homeless-
ness have reported continuous abstinence for 6 months [6]. However, our results compare
favourably with the 24-hour point prevalence abstinence rate (4%) reported at 26 weeks by
Segan et al. [13] and the 5.6% and 9.3% 7-day point prevalence at 26 weeks in a larger sample
of 430 smokers experiencing homelessness who received either NRT or motivational inter-
viewing + NRT respectively [12].
Completion rates of HRQoL and general healthcare and social services questionnaires sug-
gest that the use of these measures was feasible in this population. The responses from the par-
ticipants also indicated the services they most relied on and the direction of future refinement
for data collection. Due to the situation this population find themselves in, certain services
(e.g. home visit from GP) appear less relevant and others such as A & E and hospital stay,
should be considered for more detailed investigation. Although the participants in the UC arm
seemed to show a higher general healthcare and social services costs and worse quality of life,
it should be noted that these results were based on observed cases and the retention in the UC
arm was not as good as in the EC arm. It was also unclear if the baseline imbalance between
arms was due to insufficient sample size or imbalance in other characteristics.
Nearly half of the total costs of intervention were contributed by training. This could be
slightly underestimated as we did not include administration tasks done, in person, with e-
mail or by phone, before and after actual training delivery. However, this should not add
much to the mean costs after allocating evenly to all participants. Insufficient estimation of the
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workload in participating centres meant that we were unable to capture what was happening
in the UC arm in terms of their contacts with participants and how much efforts the keywor-
kers might have made. From self-reported SSS use, few participants in the UC arm sought SSS
for quitting and they did not ask for help from GP services either after 4 weeks. While the EC
arm did not seek SSS at all during the study period, they seemed to resort to GP services when
they were no longer offered help by their keyworkers in the centre. This might indicate an
attempt to keep on the efforts by some participants in the EC arm.
To our knowledge, this is the first study in the UK to engage with people accessing homeless
services to support smoking cessation, and the first worldwide to explore the feasibility of sup-
plying free EC starter kits. It is also the first to collect data on sustained abstinence for six
months, the Russell gold standard usually adopted for smoking cessation studies [65]. Recruit-
ment, retention, engagement and cessation rates compared favourably with previous studies.
Our participants were open and willing to using EC and there were very few unintended con-
sequences (e.g. device theft, adding illicit substances or deterioration in mental health). How-
ever, there were several limitations. Firstly, as a feasibility cluster randomised trial, we did not
meet our original target recruitment rate. Nevertheless, this was a pragmatically chosen target
based on information available to us at the time and there was further interest in participation
if our schedule had allowed the researchers to remain on site for a longer period. Secondly,
and relatedly, recruitment and retention differed across sites. This is an important finding,
which, along with the results of our process evaluation (reported elsewhere) will assist us in
carefully selecting sites (e.g. day-care only) in a future main trial. Thirdly, our arms differed on
some important baseline characteristics. However, our intention was not to formally compare
cessation rates between arms, but to inform the sample size and number of clusters required
for a main trial. Fourthly, there was evidence of cross-contamination with EC use in the UC
arm. This is a common issue in EC assisted smoking cessation research and one that will be
carefully considered in the design of a future main trial. Finally, blinding was not possible for
the measurement of outcomes which may have led to assessment bias or differential efforts on
the part of researchers in contacting participants for follow up. Nevertheless, although follow
up rates did differ between the arms, this appeared to be due to site differences rather than dif-
ferences between treatment groups per se. In terms of generalisability, although our sample
was relatively small, the data are drawn from three geographically distinct areas of GB, from a
variety of different centres and the sample demographics match those of the wider homeless
population (homeless.org).
Conclusions
Our study demonstrated promising evidence of acceptability and efficacy of offering free EC
starter kits to smokers accessing homelessness centres, a group that are among the most vul-
nerable and hard to reach in the UK. The findings of the study will be used to help inform the
design of a main trial to definitively explore the efficacy of supplying EC starter kits to smokers
accessing homeless services for smoking cessation in the UK.
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